Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Methods Mol Biol. 2021;2223:87-100. doi: 10.1007/978-1-0716-1001-5_7.
Allergic contact dermatitis (ACD) is a common skin disease with high prevalence in work environments. Human allergic contact dermatitis is triggered by the exposure to haptens that leads to an initial phase known as sensitization. During this phase, hapten-protein complexes presented by antigen-presenting cells activate a T-cell-mediated response, leading to the generation of memory cells against the hapten. Upon re-exposure to the same hapten, the elicitation phase is initiated. This phase is characterized by a quicker acute inflammatory response involving activation and/or infiltration of a variety of immune cell populations. Human ACD can be studied through the use of animal models of contact hypersensitivity (CHS). The 2,4-dinitrofluorobenzene (DNFB)-induced CHS model is a commonly used mouse model that has been helpful in the study of the mechanisms as well as potential therapeutic interventions of ACD. In this chapter I will provide a detailed protocol to develop acute DNFB-induced CHS in mice in a period of 7 days. In addition, I will discuss several key considerations for experimental design including best controls, potential expected outcomes, and sample collection.
变应性接触性皮炎(ACD)是一种常见的皮肤病,在工作环境中发病率很高。人类变应性接触性皮炎是由接触半抗原引起的,导致一个称为致敏的初始阶段。在这个阶段,由抗原呈递细胞呈递的半抗原-蛋白复合物激活 T 细胞介导的反应,导致针对半抗原的记忆细胞的产生。当再次暴露于相同的半抗原时,引发阶段就开始了。这个阶段的特点是更快的急性炎症反应,涉及多种免疫细胞群的激活和/或浸润。人类 ACD 可以通过使用接触超敏反应(CHS)的动物模型来研究。2,4-二硝基氟苯(DNFB)诱导的 CHS 模型是一种常用的小鼠模型,它在研究 ACD 的机制以及潜在的治疗干预方面很有帮助。在本章中,我将提供一个详细的方案,在 7 天内诱导小鼠发生急性 DNFB 诱导的 CHS。此外,我将讨论实验设计的几个关键考虑因素,包括最佳对照、预期的潜在结果和样本收集。